Table 1 |
|||||||
|
Genes previously reported to be regulated by transforming growth factor beta (TGF-β) |
|||||||
| Response |
Response |
||||||
|
|
|
||||||
| Gene |
1 hour |
6 hours |
24 hours |
Gene |
1 hour |
6 hours |
24 hours |
|
|
|||||||
| Cellular communication |
Cell cycle regulator |
||||||
| Platelet-derived growth factor |
No |
Up** |
Up*** |
CDK2 interacting protein (CINP) |
Down* |
No |
Down* |
| Fibroblast growth factor regulated |
Up** |
Up*** |
Up*** |
Cyclin D2 |
No |
Down* |
Down* |
| Cadherin 1 (Cdh1) |
No |
Down* |
No |
Cyclin D3 |
Up* |
No |
No |
| Signal transduction |
CDK9 |
Up* |
Up** |
Up* |
|||
| Nfkb inducing kinase |
Up** |
No |
No |
Cdk4 |
Down* |
No |
No |
| RhoB |
Up*** |
Up*** |
Up** |
Cyclin A2 |
Down* |
No |
Down* |
| Serine/threonine kinase 25 |
No |
Up* |
No |
Cyclin B1 |
No |
No |
Down** |
| Integrin β4 |
No |
Up** |
No |
Cyclin B2 |
Down* |
No |
Down* |
| Bmp-1 |
No |
Up* |
Up* |
Cdc25a |
No |
Up* |
No |
| Janus kinase 2 (Jak2) |
No |
No |
Up* |
Cyclin H |
No |
No |
Down* |
| Integrin α3A |
No |
No |
Up* |
Cancer |
|||
| Integrin β1 |
No |
Up* |
Up** |
c-myc |
Down** |
Down* |
No |
| Integrin-linked kinase (Ilk) |
No |
Up* |
Up* |
Akt |
Up** |
No |
No |
| Integrin β5 |
Up* |
Up** |
Up*** |
GRO1 oncogene |
Down** |
Down** |
Down** |
| Tyrosine phosphatase PTPT9 |
No |
Up* |
Up* |
Jun oncogene |
Up** |
No |
Up* |
| Ephrin-A1 (EFNA1) |
Up* |
No |
No |
E2 oncogene (Ets1) |
Up** |
Up** |
Up* |
| BMP-6 |
No |
Up* |
Up** |
Transport |
|||
| TGF-β1-induced transcript |
Up* |
Up** |
Up*** |
Glucose transport protein |
Up* |
No |
No |
| Colony stimulating factor 1 |
Up** |
Up** |
Up*** |
Ubiquitins and elongation factors |
|||
| Intracellular components |
Elongation factor 2 (ef-2) |
No |
Up** |
Up** |
|||
| TG interacting factor (Tgif) |
Up* |
Up** |
Up** |
Ubiquitin conjugating enzyme |
Up* |
Up* |
Up* |
| α-actinin |
No |
Up** |
Up** |
Enzyme |
|||
| β-tropomyosin 2 |
No |
Up* |
Up*** |
Glutathione S-transferase |
Down* |
Down* |
Down* |
| Catenin src (Catns) |
No |
Up* |
Up* |
Protein tyrosine phosphatase |
Up* |
No |
No |
| Extracellular components |
Protease serine 15 (PRSS15) |
Up* |
Up* |
No |
|||
| α1 type IV collagen |
No |
No |
Up* |
Aldose reductase |
No |
Up** |
Up** |
| Fibronectin |
No |
Up* |
Up*** |
Disulfide isomerase (ERp59) |
No |
Up* |
No |
| Nucleic acid binding |
Casein kinase II (Csnk2a2) |
No |
Up* |
No |
|||
| Helix-loop-helix DNA binding (Id) |
Up*** |
Down*** |
Down*** |
Ornithine decarboxylase |
No |
Up** |
Up** |
| Inhibitor of DNA binding (Idb3) |
No |
Down* |
Down* |
RNA polymerase II |
No |
No |
Up* |
| Translation initiation factor 2 |
No |
No |
Up* |
Bruton's tyrosine kinase (Btk) |
No |
Up* |
Up* |
| Id2 |
No |
Down* |
Down* |
Cytochrome b-5 reductase (DIA1) |
No |
No |
Up* |
|
|
|||||||
|
The genes presented were upregulated (up) or downregulated (down) at least 2.5-fold (* 2.5-fold to fourfold, ** fourfold to sixfold, *** above sixfold) and were found in a Medline search in which the gene name and TGF-β1 were used as keywords. The genes are grouped according to their involvement in specific cellular functions. |
|||||||
|
Xie et al. Breast Cancer Res 2003 5:R187 doi:10.1186/bcr640 |
|||||||